Based on the systematic examination of the target of human TFs, we found that, CCAAT enhancer binding protein delta (C/EBP-delta, CEBPD) is the top TF that controls the greatest number of HRGs in GBM. This evidence concerns the gene CEBPD and glioblastoma.